BioForce Nanosciences Flags Zero Revenue, Going Concern, and Control Weaknesses in Q2 2026
BFNH has more than doubled off its 52-week low of $0.163.
Summary
BioForce Nanosciences' Q2 2026 filing reveals zero revenue, a going concern warning, and material weaknesses. Cash stands at just $307 as the company pivots to oil and gas exploration with unproven leases.
Key Events · Earnings and Guidance · BFNH
-
Zero Revenue and Going Concern Warning
For the three and six months ended June 30, 2026, the company reported no revenue and reiterated a going concern warning, holding only $307 in cash. Operations are currently sustained by a legal settlement; once those funds are exhausted, the company will rely on officer loans.
-
Material Weaknesses in Internal Controls
Management disclosed material weaknesses in internal controls over financial reporting, citing inadequate segregation of duties and insufficient review of the financial reporting process—deficiencies that could lead to material misstatements.
-
Stock Payable of $2.48 Million for Services
A total of $2,484,300 in stock payable is outstanding for 4 million restricted shares to advisory board members and legal counsel, plus 200,000 shares to the former chairman and 316,909 shares to the interim CEO, all priced at $0.55 per share. None of these shares have been issued yet.
-
Oil and Gas Lease Acquisition from Related Party
The company received assignment of 11 federal oil and gas leases covering 19,957 acres in Nevada from a related party controlled by the majority shareholder. Valued at $234,525, the leases have no proven reserves and no wells have been drilled.
Analysis · BFNH · Industrial Applications And Services
The Q2 2026 quarterly report from BioForce Nanosciences Holdings, Inc. lays bare a precarious financial position: zero revenue, a going concern warning, and material weaknesses in internal controls. With just $307 in cash, the company is funding operations through a legal settlement and will turn to officer loans once that runs dry. The filing also reveals a strategic pivot to oil and gas exploration, backed by 20,000 acres of unproven leases acquired from a related party. Although no shares were issued during the quarter, $2.48 million in stock payable for advisory, legal, and bonus shares signals potential future dilution. The convergence of no revenue, a going concern warning, and material weaknesses makes this a critical update for investors.
At the time of this filing, BFNH was trading at $2.23 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $74.6M. The 52-week trading range was $0.16 to $2.30. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.